February 28, 2015 11:40 AM ET


Company Overview of Addrenex Pharmaceuticals, Inc.

Executive Profile

Moise A. Khayrallah Ph.D.

Co-Founder and Chief Executive Officer, Aerial BioPharma LLC
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Moise A. Khayrallah, Ph.D. is a Co-Founder of Neuronex, Inc., and serves as its Chief Executive Officer and President. Dr. Khayrallah co-founded Aerial BioPharma LLC in 2011 and serves as its Chief Executive Officer. He was Co-Founder of Addrenex Pharmaceuticals, Inc. and served as its President and Chief Executive Officer. Dr. Khayrallah has been involved in drug development for close to 23 years in executive as well as research and development positions. From 1999 ...

Corporate Headquarters

4825 Creekstone Drive
Durham, North Carolina 27703-8051

United States

Phone: 919-941-0800
Fax: 919-941-0802

Board Members Memberships

President, Chief Executive Officer, Co-Founder, and Director


University Of North Carolina At Chapel Hill

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Addrenex Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.